Health TrialsbyHealthPanel

MAPS PrEP Van Study

ConditionHIV Infection
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorDuke University

About this trial

For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

18 years or older, active drug injection user and/or sexually active, referred from the Syringe Service Program

Disqualifiers

positive HIV status

Trial design

Design model

Single group

Treatments tested in this trial

  • Pre-Exposure Prophylaxis (PrEP)

    Drug

    Oral Pre-Exposure Prophylaxis (PrEP) pills

Treatment groups

20 Participants
are divided into 1 treatment group
Group A: PrEPExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Enrollment

Number of participants utilizing medical mobile unit during study duration who are eligible for PrEP

Time frame
Baseline
2

Negative HIV Status

Number of participants who remain HIV negative at 3 months (Measured via negative HIV test at 3 months

Time frame
up to 3 months
3

PrEP Consultation

Number of participants who agree to PrEP consultation

Time frame
up to 6 months
4

PrEP Initiation

Number of participants who complete PrEP consultation and start PrEP

Time frame
up to 6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Duke University

Lead sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborator

Source ClinicalTrials.gov
Apply now